Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation#.

by Berhane eGhebrehiwet, Jolyon eJesty, Sulan eXu, Rama eVinayagasundaram, Uma eVinayagasundaram, Yan eJi, Alisa eValentino, Kinga H. Hosszu, Sally eMathew, Kusumam eJoseph, Allen P. Kaplan, Ellinor I.B. Peerschke
Published 2011-11-01